TNFSF11 and postmenopausal osteoporosis: Jiang et al.'s study suggested that regulating the nuclear factor erythroid 2‐related factor 2/DNA methyltransferases 3A/RANKL axis of osteocytes effectively alleviated the development of postmenopausal osteoporosis by inhibiting ferroptosis.50